PI
Pharmstandard International Portfolio holdings
AUM
$29M
1-Year Return
2.12%
This Quarter Return
+20.28%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$39.6M
AUM Growth
+$39.5M
(+48,225%)
Cap. Flow
+$152K
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
ARGS
Argos Therapeutics, Inc.
ARGS
|
+$152K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
1
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14.8M | 37.17% |
662,063
| – | – |
|
|
ALNA
2
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $11.4M | 28.71% |
1,037,267
| – | – |
|
3
Protagonist Therapeutics
PTGX
$3.61B
| $8.44M | 21.2% |
982,270
| – | – |
|
4
Protara Therapeutics
TARA
$120M
| $4.17M | 10.47% |
41,698
| – | – |
|
|
ARGS
5
DELISTED
Argos Therapeutics, Inc.
ARGS
| $744K | 1.87% |
826,153
+169,014
| +26% | +$152K |
|